Page last updated: 2024-10-20

pyrazinamide and Amyloidosis

pyrazinamide has been researched along with Amyloidosis in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Amyloidosis: A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Li, DF1
Yao, J1
Wang, LS1
TANI, P1
POPPIUS, H1

Other Studies

2 other studies available for pyrazinamide and Amyloidosis

ArticleYear
Ileal amyloidosis mimicking Crohn´s disease as a cause of chronic diarrhea.
    Revista espanola de enfermedades digestivas, 2021, Volume: 113, Issue:12

    Topics: Amyloidosis; Antitubercular Agents; Crohn Disease; Diarrhea; Drug Therapy, Combination; Female; Huma

2021
SIDE EFFECTS OF AN ANTITUBERCULOUS FIVE-DRUG REGIMEN: ETHIONAMIDE, CYCLOSERINE, PYRAZINAMIDE, VIOMYCIN AND ISONIAZID.
    Acta tuberculosea et pneumologica Scandinavica, 1963, Volume: 43

    Topics: Amyloidosis; Antitubercular Agents; Cycloserine; Deafness; Drug Hypersensitivity; Duodenal Ulcer; Et

1963